← Back to all substances
N

fluoxetine

245ms
Level 1

✓ What this shows

  • • Reported adverse events from FDA FAERS
  • • Descriptive statistics from a locked corpus
  • • Data verified with cryptographic hashes

✗ What this is NOT

  • • Not medical advice or recommendations
  • • Not proof of causality
  • • Not a complete safety profile

About this substance

1 INDICATIONS AND USAGE Fluoxetine is indicated for the treatment of: Acute and maintenance treatment of Major Depressive Disorder [see Clinical Studies (14.1) ] . Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD) [see Clinical Studies...

Known as: Fluoxetine
Route: ORAL
Source: OpenFDA Drug Labels · Reference only · Not medical advice
500
Events in Corpus
v20260131-01
82,775
Total in FDA
83%
Serious Reports
79
Fatal Outcomes

Seriousness

Serious
413
Non-Serious
87

Sex Distribution

Male
161
Female
326
Unknown
13

Age Distribution

0-17
34
18-40
126
41-64
196
65-84
64
85+
14
Unknown
66

Outcomes

Recovered/Resolved
416
Recovering/Resolving
171
Not Recovered/Not Resolved
282
Recovered with Sequelae
42
Fatal
79
Unknown
914

Top Reported Reactions (click to view reports)

Verification Data

Corpus Version: v20260131-01
Root Hash: ec5727564d1ed19be5b08b26d3866f446b12d3d388f5a8cd713332c6d97ad264
Stats Hash: N/A
EVE Decision ID: EVE-MED-20260402-fb17ef
ℹThis output reports adverse events from FDA FAERS. It does not constitute medical advice.

Molecular Structure (reference)

Structural visualization for identification only.

This visualization shows the molecular structure for identification purposes only. It does not represent pharmacological effect, safety, or clinical relevance.

Loading structure...